Regulation of Proteasome Activity
蛋白酶体活性的调节
基本信息
- 批准号:10707061
- 负责人:
- 金额:$ 49.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectBindingCaenorhabditis elegansCellsComplexDeubiquitinating EnzymeDiseaseEnzymatic BiochemistryEnzymesEukaryotaGeneticImpairmentLaboratoriesLongevityMediatingMethodsNerve DegenerationOutputPathway interactionsPeptide HydrolasesPerceptionProteinsProteomicsRegulationReportingRoleSpecificityStressStructureSubstrate SpecificitySystemTimeUbiquitinWorkYeastsfascinategenetic analysisinterestmodel organismmulticatalytic endopeptidase complexmutantpolyglutamineproteostasisreceptorreconstitutionrecruitsingle moleculestructural biologyubiquitin isopeptidaseubiquitin ligase
项目摘要
PROJECT SUMMARY / ABSTRACT
The focus of my laboratory’s efforts is the proteasome, the protease that degrades ubiquitin-protein
conjugates. That the proteasome is the central activity within the ubiquitin-proteasome system (UPS) was known
from the time the UPS was charted, but its significance was not fully recognized at the time because the
proteasome was presumed, incorrectly, to be unregulated and passive–essentially a dumb enzyme. But this
perception has been overturned by the progressive identification of diverse mechanisms that finely regulate
proteasome synthesis, turnover, localization, substrate specificity, and specific activity. These mechanisms are
of special interest because they provide the means for global control of UPS output. In parallel, evidence of the
importance of proteasome activity in disease has accumulated. For example, even a modest elevation of
proteasome levels substantially increases the lifespan of D. melanogaster and C. elegans, as well as their ability
to withstand stresses such as the expression of toxic polyQ proteins. A fascinating mode of proteasome
regulation is that involving the dynamic reconfiguration of ubiquitin chains on a substrate at the proteasome. Two
such chain-editing factors are highly active as well as conserved across eukaryotes: Ubp6/USP14 and
Hul5/UBE3C. Ubp6 is a deubiquitinating enzyme and Hul5 is a ubiquitin ligase, and they work in opposition to
one another; Ubp6 will remove ubiquitin groups added to the substrate by Hul5. Both are recruited to
proteasomes when the UPS is impaired or challenged. The specificity of Ubp6 is remarkable in that it acts only
on substrates that carry multiple ubiquitin chains. We will characterize this specificity further and investigate its
mechanistic basis. We have reported that Hul5 functions as an E4 on the proteasome–it ubiquitinates proteins
that are already ubiquitinated. We will focus now on how this E4 activity promotes the processivity of the
proteasome, as Hul5 appears to be the main regulator of processivity. We will reconstitute the processivity effect
in a purified system and use highly specific mutants in Hul5 in single-molecule analysis. We will also investigate
the mechanisms by which Ubp6 and Hul5 are controlled by stress. The third major factor recruited to
proteasomes under proteostasis stress is Ecm29, which has the unique feature of binding both the RP and CP.
Ecm29 regulates both the activity and assembly of the proteasome, most likely by bridging these complexes.
Our studies will focus on how Ecm29 is recruited to faulty proteasomes and how it affects their structure and
stability. Finally, substrate recognition by the proteasome is mediated by six distinct ubiquitin receptors. However,
our detailed genetic analysis in yeast indicates the existence of at least one additional, unknown ubiquitin
receptor within the proteasome. We will attempt to identify this receptor, and once we generate suitably precise
mutants we will explore this receptor’s role in substrate recognition and processing. In summary, we propose,
by applying the methods of genetics, enzymology, structural biology, and quantitative global proteomics, to
elucidate major pathways of proteasome function and regulation.
项目摘要 /摘要
我实验室努力的重点是蛋白酶体,蛋白酶会降解泛素 - 蛋白质
共轭。蛋白酶体是泛素 - 蛋白酶体系统(UPS)中的中心活动
从UPS绘制的时间开始,但当时它的意义尚未得到完全认可,因为
蛋白酶体是错误地提出的,不受监管和被动地提出了一种愚蠢的酶。但这
通过对细节调节的潜水机制的逐步识别,人们已经推翻了感知
蛋白酶综合,周转,定位,底物特异性和特定活性。这些机制是
特别感兴趣,因为它们为全球控制UPS输出提供了手段。同时,证据
蛋白酶体活性在疾病中的重要性已积累。例如,即使是适度的海拔
蛋白酶体水平大大提高了梅拉诺斯特和秀丽隐杆线虫的寿命,以及它们的能力
承受诸如有毒Polyq蛋白的表达之类的应力。一种迷人的蛋白酶体模式
调节是涉及泛素链在蛋白酶体处的底物上的动态重新配置。二
这种链条编辑的因素高度活跃,并且在整个真核生物中保持了保守:UBP6/USP14和
HUL5/UBE3C。 UBP6是一种去泛素化酶,HUL5是一种泛素连接酶,它们与反对
彼此; UBP6将通过HUL5删除添加到底物中的泛素组。两者都被招募到
当UPS受到损害或挑战时的蛋白酶体。 UBP6的特异性非常出色,因为它仅行动
在携带多个泛素链的底物上。我们将进一步表征这种特异性并研究其
机械基础。我们报告说,HUL5在蛋白质组上充当E4 - 它泛素蛋白质
已经泛素化了。现在,我们将重点关注E4活动如何促进
蛋白酶体,因为HUL5似乎是加工性的主要调节剂。我们将重建过程效应
在纯化的系统中,在单分子分析中使用HUL5中的高度特异性突变体。我们还将调查
UBP6和HUL5由应力控制的机制。招募的第三个主要因素
蛋白质抗压胁迫下的蛋白酶体是ECM29,其具有结合RP和CP的独特特征。
ECM29调节蛋白酶体的活性和组装,最有可能通过桥接这些复合物来调节。
我们的研究将重点介绍如何将ECM29招募到错误的蛋白酶体以及它如何影响其结构和
稳定。最后,蛋白酶体的底物识别是由六个不同的泛素接收器介导的。然而,
我们在酵母中的详细遗传分析表明存在至少一个额外的未知泛素
蛋白酶体内的受体。我们将尝试识别该受体,一旦我们产生了适当的精确
突变体我们将探讨该接收器在底物识别和处理中的作用。总而言之,我们建议
通过应用遗传学,酶学,结构生物学和定量全球蛋白质组学的方法
阐明蛋白酶体功能和调节的主要途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel J Finley其他文献
Daniel J Finley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel J Finley', 18)}}的其他基金
The proteasome in aging and neurodegenerative disease
衰老和神经退行性疾病中的蛋白酶体
- 批准号:
10183115 - 财政年份:2018
- 资助金额:
$ 49.72万 - 项目类别:
Proteostasis Core: Quantitative global proteomics
蛋白质稳态核心:定量全局蛋白质组学
- 批准号:
10183112 - 财政年份:2018
- 资助金额:
$ 49.72万 - 项目类别:
The proteasome in aging and neurodegenerative disease
衰老和神经退行性疾病中的蛋白酶体
- 批准号:
10432033 - 财政年份:2018
- 资助金额:
$ 49.72万 - 项目类别:
Proteostasis Core: Quantitative global proteomics
蛋白质稳态核心:定量全局蛋白质组学
- 批准号:
10432029 - 财政年份:2018
- 资助金额:
$ 49.72万 - 项目类别:
Ubiquitin chain editing by the mammalian proteasome
哺乳动物蛋白酶体的泛素链编辑
- 批准号:
8473882 - 财政年份:2011
- 资助金额:
$ 49.72万 - 项目类别:
Ubiquitin chain editing by the mammalian proteasome
哺乳动物蛋白酶体的泛素链编辑
- 批准号:
8269828 - 财政年份:2011
- 资助金额:
$ 49.72万 - 项目类别:
Ubiquitin chain editing by the mammalian proteasome
哺乳动物蛋白酶体的泛素链编辑
- 批准号:
8688267 - 财政年份:2011
- 资助金额:
$ 49.72万 - 项目类别:
Ubiquitin chain editing by the mammalian proteasome
哺乳动物蛋白酶体的泛素链编辑
- 批准号:
8108436 - 财政年份:2011
- 资助金额:
$ 49.72万 - 项目类别:
相似国自然基金
结合态抗生素在水产品加工过程中的消解机制与产物毒性解析
- 批准号:32302247
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ABHD6与AMPA受体结合位点的鉴定及该位点在AMPA受体转运和功能调控中的作用研究
- 批准号:32300794
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-突触核蛋白与脂肪酸结合蛋白FABP3相互作用维持自身低聚体形态的机制研究
- 批准号:82301632
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于荧光共振能量转移机理构建多肽荧光探针用于可视化Zn2+结合SQSTM1/p62调节自噬在前列腺癌去势耐受中的作用机制
- 批准号:82303568
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
手性氢键供体与阴离子结合催化乙烯基醚的立体选择性阳离子聚合
- 批准号:22301279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 49.72万 - 项目类别:
Non-Canonical Roles for Cell-Adhesion Molecules in Presynaptic Assembly
细胞粘附分子在突触前组装中的非典型作用
- 批准号:
10751904 - 财政年份:2023
- 资助金额:
$ 49.72万 - 项目类别:
Cell-Intrinsic Mechanisms of Presynaptic Assembly
突触前组装的细胞内在机制
- 批准号:
10786383 - 财政年份:2023
- 资助金额:
$ 49.72万 - 项目类别:
Elucidating the mechanisms by which ectopically expressed genes and piRNAs perturb somatic cell function when histone methylation is inappropriately regulated
阐明组蛋白甲基化调节不当时异位表达基因和 piRNA 扰乱体细胞功能的机制
- 批准号:
10730632 - 财政年份:2023
- 资助金额:
$ 49.72万 - 项目类别: